Sotalol Pellets

(Product under development)
Sotalol PelletsSotalol is a drug used in individuals with rhythm disturbances (cardiac arrhythmias) of the heart, and to treat hypertension in some individuals.

It is a non-selective competitive β-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties by its inhibition of potassium channels.

Because of this dual-action, Sotalol prolongs both the PR interval and the QT interval. Originally discovered around 1960, sotalol became widely used first as a β-blocker in the 1980s, and its function as an antiarrhythmic drug was discovered soon after.

Due to the dual action of sotalol, it is often used preferentially to other β-blockers as treatment for both ventricular fibrillation and ventricular tachycardia.

Available Form:
Sotalol Pellets
Sotalol Granules

Umang Pharmatech equipments used for production of Sotalol Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.


Sotalol Pellets
Systematic (IUPAC) Name
Sotalol Pellets
Identifiers
Sotalol Pellets
Chemical data
(RS)-N-{4-[1-hydroxy-2-(propan-2-ylamino)
ethyl]phenyl}methanesulfonamide
CAS number : 3930-20-9
ATC code : C07AA07
PubChem : CID 5253
DrugBank : DB00489
ChemSpider : 5063
UNII : A6D97U294I
KEGG : D08525
ChEMBL : CHEMBL471
Formula : C12H20N2O3S
Mol. mass : 272.3624 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL